Article Details
Retrieved on: 2021-04-28 14:15:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... agreement with Beijing-based AcornMed Biotechnology to develop products for minimal residual disease detection in genitourinary tract cancer and ...
Article found on: www.genomeweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here